Senator Kirkpatrick introduces AI guardrails for prior authorization; panel presses on speed and licensing

Senator Kirkpatrick told the Senate Rules Committee that Senate Bill 444 would preserve a "human in the loop" for prior-authorization reviews when artificial intelligence is used, keeping a clinical peer involved before any adverse determination.

"We have done a lot of work on this process over the last several years on prior authorization," the senator said, adding that SB 444 "continues the work that we've done previously to be sure that AI cannot supersede the judgment of a clinical peer." The sponsor described safeguards including a clinical peer review component.

Committee members pressed for operational clarity. Jim Martin asked whether requiring human review would slow approvals for cases likely to be approved; the sponsor responded that the bill is designed to allow AI to process approvals but require human review when AI would issue a denial so the whole medical record is reviewed. Another member asked whether denials should only be made by a provider licensed to practice in Georgia; the sponsor referred to an earlier definition of a clinical peer used in a prior bill and stated that the bill relies on that standard.

Why it matters: As insurers and providers increasingly use AI tools, states are weighing guardrails to prevent automated systems from issuing adverse health decisions without clinician oversight. Proponents framed SB 444 as balancing innovation with patient protection; reviewers sought guarantees that safeguards would not slow necessary approvals.

Senator Kirkpatrick also presented SB 395 to improve communication between the Department of Public Health and the Composite State Medical Board for the medical-cannabis program; committee members said they saw broad agreement on that bill.